The INVEST Precision Medicine conference cast a spotlight on the role of children's hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.
This panel explores some of the diverse approaches companies are taking to improve efficiency and avert pitfalls in therapeutic development.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The clinical trial arena is changing rapidly, driven largely by the acceleration of telehealth usage and the potential provided by new data solutions. Panelists at MedCity INVEST Precision Medicine agreed that clinical trials will never be conducted in the same way again.
Register for INVEST Precision Medicine to check out the life science track of the Pitch Perfect startup contest and hear compelling panel discussions on software supporting biopharma R&D, and the supply chain challenges of scaling production and delivering personalized therapies.
Late last month, Medable and LabCorp CRO Covance signed a deal to accelerate adoption of decentralized trials, a trend that has been helped along as Covid-19 has created challenges to conducting trials dependent on traditional brick-and-mortar sites.
The report, by CRO Worldwide Clinical Trials, shows growing need for early-stage development expertise, with high demand for data quality, efficiency and overall trial management.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Burlington, North Carolina-based LabCorp is rumored to be negotiating an $8 billion acquisition of Pharmaceutical Product Development (PPD), a global contract research organization operating in over 50 countries.